State Street’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
SCM
BGI
JT
OCA
PA
RCM
State Street's PALI Position: Q2 2026 in Review
State Street increased its Palisade Bio (PALI) stake by 289% in Q2 2026, buying an estimated $3.62M and bringing the position to 2,475,648 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.
State Street first reported a position in PALI in Q2 2014 and has held it in 17 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.
- State Street held 2,475,648 shares of Palisade Bio worth $5.17M as of Q2 2026.
- State Street bought 1,839,451 Palisade Bio shares in Q2 2026, an estimated $3.62M.
- Palisade Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2997 holding.
- State Street first reported a position in Palisade Bio in Q2 2014 and has held it in 17 quarters since.
- 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.